Mouse IFN-γ T cell ELISPOT antibody pair - 20-plate

SKU
CT655-20
Validated ELISPOT antibody pair; reagents available separately (1920 determinations).
Format
20-plate
Price
€ 1,160
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT antibody pairs are validated for high assay performance using the same reagents and materials included in U-CyTech ELISPOT kits. These antibody pairs are optimized for reliable and reproducible ELISPOT assays.
The antibody pairs are available in convenient 10-plate and 20-plate format, providing 960 or 1920 determinations, respectively.
Compatible reagents for ELISPOT assays can be purchased separately, allowing customization of your ELISPOT workflow.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978

References

Authors, et al. Title Journal Year Volume Pages
Wanhong Yao Enhanced immune response and protection efficacy of a DNA vaccine constructed by linkage of the Mycobacterium tuberculosis Ag85B-encoding gene with the BVP22-encoding gene J Med Microbiol 2009 58 462-468
Hui Hu Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model Vaccine 2009 27 1758-63
Pan Tao Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice Antiviral Res 2009 81 253-60
Quanjiao Chen Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus Virus Genes 2009 38 30-8
Jiu Wang Evaluation of a recombinant BCG expressing antigen Ag85B and PPE protein Rv3425 from DNA segment RD11 of Mycobacterium tuberculosis in C57BL/6 mice Med Microbiol Immunol 2009 198 5-11
Liyun Zheng A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice BMC Infect Dis 2009 9 17
Victoria Velazquez Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy Blood 2009 113 538-45
Anthony Cristillo HIV-1 Env vaccine comprised of electroporated DNA and protein co-administered with Talabostat Biochem Biophys Res Commun 2008 370 22-6
Ye-Jun Wang Two oral HBx vaccines delivered by live attenuated Salmonella: both eliciting effective anti-tumor immunity Cancer Lett 2008 263 67-76
Tao Bian Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice Mol Cancer Ther 2008 7 1329-35